A COVID-19 vaccine jointly developed by the Institute of Microbiology of the Chinese Academy of Sciences and a unit of Chongqing Zhifei Longcom Biopharmaceutical Co., Ltd. has obtained the greenlight for emergency use in China, according to a news report published by Reuters on March 15.
点击右上角微信好友
朋友圈
请使用浏览器分享功能进行分享